Virtuosi® Immersive Training Program Implemented at Samsung Bioepis

The world’s only on-demand 2D and virtual-reality simulation education platform for the pharmaceutical and biotech industries expands its reach into Asia. Virtuosi was created by the technical experts at Quality Executive Partners, Inc. to meet the needs of industry.

ALEXANDRIA, Va., Aug. 2, 2023 /PRNewswire-PRWeb/ — Pharmaceutical manufacturing and training innovations required for the industry’s Pharma 4.0 advancement have been accelerating throughout the world, most recently in South Korea, where Samsung Bioepis just adopted Quality Executive Partners Inc.’s Virtuosi immersive learning and training program for manufacturing operators.

Virtuosi’s tech-forward one-of-a-kind platform uses video courses to teach employees analytical and critical thinking skills, including the “why” behind the science. Virtuosi leverages the power of virtual reality interactive experiences to foster the long-term memory of the employee.

“Educating and training the people who make the medicines we put in our bodies is responsibility number one in the pharmaceutical industry,” noted QxP CEO Crystal Mersh, “The evidence is overwhelming that the two teaching methods used by Virtuosi – deep-dive video instruction coupled with applied learning in a virtual simulation, are far superior to the read-and-memorize approach the industry has used since its inception. We must do better because making quality drugs every single time is the commitment we owe to patients.”

Virtuosi was beta-tested by the U.K.’s Medicines and Healthcare Products Regulatory Agency and is now in use across the globe at both small biotech firms and large multinational pharmaceutical companies. In 2022, QxP expanded its catalogue of Virtuosi content to include cell and gene therapy processing. Virtuosi is available in five languages.

“We absolutely have to have Education 4.0 for Pharma 4.0, and the standardization of a company’s manufacturing practices is essential, no matter how many facilities they have or where they are located around the world,” said Mersh, “Quality is the priority and consistency is essential. Virtuosi is the only multi-language program providing that consistency.”

QxP’s installation of Virtuosi in South Korea marks a significant step in its expansion into the Asia-Pacific region.

About Virtuosi

Virtuosi is the world’s first and only comprehensive multi-language, on-demand education and virtual-reality simulation training platform for the pharmaceutical and biotech industries. The platform combines 56 in-depth technical courses in Sterile Manufacturing, Microbiology, Cell and Gene Therapy / ATMP with 26 highly immersive virtual reality experiences through which employees apply and practice the techniques they learn. Virtuosi is available in English, French, German, Spanish, and Swedish. Virtuosi is used by large and small pharmaceutical and biotech companies around the globe. https://www.virtuosivr.com/

About Quality Executive Partners, Inc.

Quality Executive Partners, Inc. (QxP) is a global management and technical GMP consulting firm providing the pharmaceutical industry with innovative solutions and revolutionary technical education programs, including Virtuosi. The mission of QxP is to ensure our clients meet their business, quality, and compliance goals simultaneously. We achieve this through a unique partnering relationship that provides technical expertise, educational tools, mentoring, and execution support. Our success is defined by providing timely delivery of those goals coupled with the transfer of knowledge and capability to the client’s team. https://www.qualityexecutivepartners.com/

Pull Quote

the two teaching methods used by Virtuosi – deep-dive video instruction coupled with applied learning in a virtual simulation, are far superior

Media Contact

Michelle Fishburne, Quality Executive Partners, Inc., 1 9192470384, mfishburne@qualityexecutivepartners.com, https://www.virtuosivr.com/

 

SOURCE Quality Executive Partners, Inc.

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

14 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

14 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

14 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

14 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

14 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

14 hours ago